BusinessTreos Bio Names Gábor Illés as Its Chief Financial OfficerBy Nasdaq OMXApr 3, 2018, 12:15 PM UTC
BusinessExosome Diagnostics Partners with Intezyne to Develop Exosomal RNA-based Assay for Novel Cancer Resistance Pathway (CRP) InhibitorBy Nasdaq OMXMar 14, 2018, 11:30 AM UTC
BusinessTreos Bio Announces FDA Approval of IND of Its First PolyPEPI™ Precision Cancer Vaccine for Metastatic Colorectal CancerBy Nasdaq OMXJan 24, 2018, 1:15 PM UTC
BusinessExosome Diagnostics Places Early Access Shahky™ Exosomal Protein Detection System at MGH Center for Systems BiologyBy Nasdaq OMXJan 9, 2018, 12:46 PM UTC
BusinessMolecularMD obtains FDA Authorization for the MRDx® BCR-ABL Test as a Companion Diagnostic for Treatment-Free Remission in Ph+ CML-CP Patients Treated with TasignaBy Nasdaq OMXDec 22, 2017, 11:02 PM UTC
BusinessExosome Diagnostics Publishes a Study Demonstrating Superior Performance of ExoLution™ Plus Liquid Biopsy Platform in Lung CancerBy Nasdaq OMXDec 19, 2017, 12:51 PM UTC
BusinessExosome Diagnostics Presents Breakthrough Liquid Biopsy Technologies at BIO International ConventionBy Nasdaq OMXJun 22, 2017, 3:55 PM UTC
